Soleus Capital Management’s Nuvectis Pharma NVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.1M Buy
1,710,658
+710,658
+71% +$15M 1.28% 22
2026
Q2
$18.4M Buy
+1,000,000
New +$11.2M 0.63% 42

Other funds holding NVCT

Soleus Capital Management's NVCT Position: Q3 2026 in Review

Soleus Capital Management increased its Nuvectis Pharma (NVCT) stake by 71% in Q3 2026, buying an estimated $15M and bringing the position to 1,710,658 shares worth $36.1M. The position accounts for 1.28% of the portfolio, ranked #22.

Soleus Capital Management first reported a position in NVCT in Q2 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • Soleus Capital Management held 1,710,658 shares of Nuvectis Pharma worth $36.1M as of Q3 2026.
  • Soleus Capital Management bought 710,658 Nuvectis Pharma shares in Q3 2026, an estimated $15M.
  • Nuvectis Pharma made up 1.28% of Soleus Capital Management's portfolio in Q3 2026, its #22 holding.
  • Soleus Capital Management first reported a position in Nuvectis Pharma in Q2 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.